Evolve products are based on anhydrous lipids with an excellent safety profile. No water is present or added to the products.
This eliminates the need for additives such as preservatives, solubilisers and corrosion inhibiters which can often exacerbate sensitive skin. Evolve Plus is CE marked as a Class 2a Medical Device and should available to prescribe, within the UK, on FP10 very shortly.
Evolve Plus contains hypoallergenic, ultra pure, second generation liquid medical grade lanolin which is a lipid similar to the those in the human stratum corneum. Since Evolve Plus does not contain Petrolatum, a flammable hydrocarbon, it presents a significantly reduced flammability risk and eliminates the concerns regarding petrolatum, mineral oil and skin cancer. For more information about skin cancer click here.
The people behind the development of the Evolve Range are as follows:
C. Paul Armstrong BSc (Hons), FCA
Managing Director with 17 years experience providing services and support to the pharmaceutical industry. He has made innovative contributions to many new medicinal products that have passed the clinical trial phases.
Dr Ian Steel BSc (Hons), PhD, CSci, CChem, FRSC
Scientific Director - Ian obtained a BSc (First Class Honours) degree in Chemical Sciences and PhD (for which he won the Cohen Prize for his research into metal-ion complexes of neuropeptides) from the University of Leeds. He then went on to do post doctoral work in both chemistry and cancer research. In 1986 he joined Westbrook Lanolin Company and in 1991 became Head of Research & Development. Between 1998 and 2007 Ian was Scientific Director of Croda Chemicals Europe Ltd. Ian is a member and fellow of numerous professional bodies and societies and is regarded as a leading authority on all aspects of lanolin particularly concerning it's safety and efficacy. In addition he worked on the development of a number of major high street skincare brands. He has presented at national and international conferences on more than fifty occasions - throughout Europe, United States, Japan, South Africa etc and has published 15 scientific papers; 8 scientific posters and 8 patents.
Dr. Ian Flockhart, BSc (Hons), PhD, CChem, FRSC
Qualified Person under EU Directives 75/319/EC and 2001/83/EC with over 30 years active involvement in analytical support and problem solving for Pharma and Healthcare Products. Ian was Principal Consultant for 20 years in his own laboratory-based company, offering support services to Pharmaceutical and Healthcare companies. Experienced in auditing manufacturing, distribution and analytical facilities. Experienced in selection or development, evaluation and validation of analytical methodology for a wide range of pharmaceutical and healthcare compounds.
NEXT PAGE...